Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
98.73 -0.69 / -0.69%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
98.72 -0.0099 / -0.01%
 
Volume: 16.2K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line20.0M-25.3M-42.9M-95.5M
 
 
 
 
 
Depreciation364.0K999.8K4.3M5.6M
 
 
 
 
 
Total Other Cash Flow985.0K924.7K5.6M14.2M
 
 
 
 
 
Funds From Operations2.8M-23.4M-33.1M-75.7M
 
 
 
 
 
Funds From/For Other Operating Expenses5.3M-6.8M-2.1M-709.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.5M-16.6M-30.9M-75.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-195.4M-426.0M
 
 
 
Decrease In Investments1.0M0.000.00272.0M
 
 
 
Capital Expenditures0.00-682.9K-4.1M-14.6M
 
 
 
 
Other Investing - Uses0.000.000.00-1.9M
 
 
Other Investing - Sources0.0050.1M0.000.00
 
 
Net Cash Flow Investing238.0K49.4M-199.5M-173.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0012.5M0.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.00186.2K194.1M286.4M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing0.0012.7M194.1M286.4M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---4.0K-6.0K9.0K
 
 
 
 
 
Net Change In Cash-2.3M45.5M-36.3M38.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account